Please login to the form below

Not currently logged in
Email:
Password:

Boehringer launches Facebook game

Syrum aims to teach players about the complexity of medicine development

Boehringer facebook syrum 

German drug maker Boehringer Ingelheim has launched its highly anticipated 'social game' Syrum across Europe.

Developed as an application for Facebook, Syrum is the first of its kind for the pharma industry and aims to educate players through a combination of gaming and social interactivity.

Unveiled at a consumer-style launch at the London Science Museum, the game spent more than two years in development and has been designed to help explain some of the processes of medicine research.

"The use of gaming in education has been put to effective use all over the world as more organisations appreciate that humans are better motivated and stimulated by interaction, fun and engagement", said Dr Jez Rose, behavioural psychologist from Buckinghamshire.

"Syrum is a fantastic example of how fun gaming can be used to provide educational delivery, whilst maintaining interest and engagement through a logical platform-learning style."

Based around a virtual laboratory, Syrum players can develop their own imaginary medicines based around molecular compounds that can also be traded with other players.

"The research driven pharmaceutical industry is immersed in education – whether aimed at medical or pharmaceutical professionals or providing information directly to the public," said John Pugh, director of digital, Boehringer.

"Gaming is an experimental way for Boehringer Ingelheim to do this. The challenge is to do this in a truly engaging, educational and entertaining way that immerses the player."

Built into Facebook, Syrum has initially been launched in a beta format outside the US and Canada, but the company is planning a full global launch next year.

14th September 2012

From: Marketing, Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics